The medtech industry hit a slight lull in the early stages of 2021 and, after signs of a rebound, it has soared beyond levels ever before seen. MassDevice‘s MedTech 100 Index had been building up steam in the month of April, rising from 102.16 points at the beginning of March all the way to 109.39 to […]
DiaSorin
DiaSorin to buy Luminex for $1.8B
DiaSorin announced that it agreed to acquire Luminex in an all-cash transaction worth approximately $1.8 billion. Saluggia, Italy-based DiaSorin’s purchase at $37 per share of Luminex represents a 23.1% premium to Luminex shareholders based on the unaffected closing stock price of the company on Feb. 24, 2021, which was the date prior to press rumors […]
MedTech 100 roundup: Ringing in the New Year with another high
For the third time in the past four weeks, stocks within the medtech industry climbed to never-before-seen heights as 2021 reared its head. Previous highs have largely been a result of the FDA granting Moderna emergency use authorization for its vaccine candidate and its subsequent rollout to the U.S., joining the one made by Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX), […]
DiaSorin gains BARDA funding for COVID-19 testing kit
DiaSorin Molecular announced that it received federal funding from BARDA for its Simplexa COVID-19 direct testing kit. Cypress, Calif.-based DiaSorin’s undisclosed funding total received from the Biomedical Advanced Research and Development Authority (BARDA) is slated to support the validation and submission of the test for FDA 510(k) clearance and the ramp-up of manufacturing capacity for […]
What kinds of COVID-19 tests are out there?
Months into the pandemic, the FDA continues to grant emergency use approval (EUA) to new tests to detect the virus that causes COVID-19 and the antibodies that indicate a person has had it. To date, the FDA has granted EUAs for 171 tests —142 molecular tests, 27 antibody tests, and 2 antigen tests. Given the ever-changing […]
